Safety and Tolerability Cerebrolysin: Well-Established Safety Profile Cerebrolysin benefits from decades of post-marketing surveillance and clinical trial safety data: Clinical Trial Safety: Across multiple RCTs, Cerebrolysin has demonstrated a tolerability profile comparable to placebo in most studies, with adverse events generally mild and transient Common Side Effects: Injection site reactions, dizziness, headache, and nausea are the most frequently reported adverse events at standard clinical doses Serious Adverse Events: Rare at therapeutic doses
Safe & Monitored Treatment Plans We provide ongoing monitoring , dose adjustments , and side effect management to maximize results while prioritizing your health and safety
Understanding how these three entities relate to each other is important for anyone evaluating a telehealth prescription program
The supplement is free from added sugar, soy, dairy, yeast, gluten, and artificial additives
Scalise et al., 2012